Geoffrey Porges analyst

Currently out of the existing stock ratings of Geoffrey Porges, 135 are a BUY (67.5%), 64 are a HOLD (32%), 1 are a SELL (0.5%).

Geoffrey Porges

Work Performance Price Targets & Ratings Chart

Analyst Geoffrey Porges, currently employed carries an average stock price target met ratio of 69.61% that have a potential upside of 28.15% achieved within 374 days. Previously, Geoffrey Porges worked at LEERINK.

Geoffrey Porges’s has documented 414 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on RCUS, Arcus Biosciences at 04-Aug-2022.

Wall Street Analyst Geoffrey Porges

Analyst best performing recommendations are on DOVA (DOVA PHARMACEUTICALS).
The best stock recommendation documented was for VRTX (VERTEX PHARMACEUTICALS) at 4/30/2020. The price target of $263 was fulfilled within 4 days with a profit of $11.8 (4.7%) receiving and performance score of 11.74.

Average potential price target upside

ABBV AbbVie ALXN Alexion Pharmaceuticals AMGN Amgen ASMB Assembly Biosciences AXLA Axcella Health BIIB Biogen CELG Celgene FGEN FibroGen GILD Gilead Sciences MOR MorphoSys AG ADR PAND Pandion Therapeutics PRNB Principia Biopharma RCUS Arcus Biosciences RDUS Schnitzer Steel Industries REGN Regeneron Pharmaceuticals TBPH Theravance Biopharma XLRN Acceleron Pharma EPZM Epizyme HALO Halozyme Therapeutics VRTX Vertex Pharmaceuticals PFE Pfizer SNY Sanofi ADR ZGNX Zogenix AZN AstraZeneca PLC ADR DOVA Dova Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$206

$23.2 (12.69%)

$153

11 days ago
(22-Nov-2024)

13/14 (92.86%)

$27.92 (15.68%)

293

Buy

$205

$22.2 (12.14%)

18 days ago
(15-Nov-2024)

2/3 (66.67%)

$39.27 (23.70%)

507

Buy

$200

$17.2 (9.41%)

$190

20 days ago
(13-Nov-2024)

12/13 (92.31%)

$28.57 (16.67%)

490

Buy

$224

$41.2 (22.54%)

$231

21 days ago
(12-Nov-2024)

12/15 (80%)

$48.86 (27.90%)

488

Buy

$215

$32.2 (17.61%)

$226

21 days ago
(12-Nov-2024)

8/10 (80%)

$39.86 (22.76%)

293

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Geoffrey Porges?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?